首页> 外文OA文献 >Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers
【2h】

Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers

机译:ErbB受体的受控二聚为同源和异二聚体的差异信号提供证据。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The four members of the ErbB family of receptor tyrosine kinases are involved in a complex array of combinatorial interactions involving homo- and heterodimers. Since most cell types express more than one member of the ErbB family, it is difficult to distinguish the biological activities of different homo- and heterodimers. Here we describe a method for inducing homo- or heterodimerization of ErbB receptors by using synthetic ligands without interference from the endogenous receptors. ErbB receptor chimeras containing synthetic ligand binding domains (FK506-binding protein [FKBP] or FKBP-rapamycin-binding domain [FRB]) were homodimerized with the bivalent FKBP ligand AP1510 and heterodimerized with the bifunctional FKBP-FRB ligand rapamycin. AP1510 treatment induced tyrosine phosphorylation of ErbB1 and ErbB2 homodimers and recruitment of Src homology 2 domain-containing proteins (Shc and Grb2). In addition, ErbB1 and ErbB2 homodimers activated downstream signaling pathways leading to Erk2 and Akt phosphorylation. However, only ErbB1 homodimers were internalized upon AP1510 stimulation, and only ErbB1 homodimers were able to associate with and induce phosphorylation of c-Cbl. Cells expressing AP1510-induced ErbB1 homodimers were able to associate with and induce phosphorylation of c-Cbl. Cells expressing AP1510-induced ErbB1 homodimers were able to form foci; however, cells expressing ErbB2 homodimers displayed a five- to sevenfold higher focus-forming ability. Using rapamycin-inducible heterodimerization we show that c-Cbl is unable to associate with ErbB1 in a ErbB1-ErbB2 heterodimer most likely because ErbB2 is unable to phosphorylate the c-Cbl binding site on ErbB1. Thus, we demonstrate that ErbB1 and ErbB2 homodimers differ in their abilities to transform fibroblasts and provide evidence for differential signaling by ErbB homodimers and heterodimers. These observations also validate the use of synthetic ligands to study the signaling and biological specificity of selected ErbB dimers in any cell type.
机译:ErbB受体酪氨酸激酶家族的四个成员参与了涉及同二聚体和异二聚体的一系列复杂的组合相互作用。由于大多数细胞类型表达ErbB家族的一个以上成员,因此很难区分不同同型和异型二聚体的生物学活性。在这里,我们描述了一种通过使用合成配体来诱导ErbB受体的同源或异源二聚化的方法,而不会受到内源性受体的干扰。将含有合成配体结合结构域(FK506结合蛋白[FKBP]或FKBP-雷帕​​霉素结合结构域[FRB])的ErbB受体嵌合体与二价FKBP配体AP1510均二聚,并与双功能FKBP-FRB配体雷帕霉素异二聚。 AP1510处理可诱导ErbB1和ErbB2同型二聚体的酪氨酸磷酸化,并募集含有Src同源2域的蛋白(Shc和Grb2)。此外,ErbB1和ErbB2同型二聚体激活下游信号通路,导致Erk2和Akt磷酸化。但是,只有ErbB1同型二聚体在AP1510刺激后被内在化,只有ErbB1同型二聚体能够与c-Cbl缔合并诱导其磷酸化。表达AP1510诱导的ErbB1同型二聚体的细胞能够与c-Cbl结合并诱导其磷酸化。表达AP1510诱导的ErbB1同型二聚体的细胞能够形成病灶。但是,表达ErbB2同型二聚体的细胞显示了五到七倍的聚焦能力。使用雷帕霉素诱导的异二聚体,我们显示c-Cbl无法与ErbB1-ErbB2异二聚体中的ErbB1缔合,最可能的原因是ErbB2无法磷酸化ErbB1上的c-Cbl结合位点。因此,我们证明了ErbB1和ErbB2同型二聚体在转化成纤维细胞的能力方面存在差异,并为ErbB同型二聚体和异源二聚体的差异信号提供了证据。这些观察结果也验证了使用合成配体研究任何细胞类型中选定的ErbB二聚体的信号传导和生物学特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号